GSK PLC closed 16.86% short of its 52-week high of £18.24, which the company reached on May 16th.

GSK has joined a lengthening list of companies that have paused diversity, equity, and inclusion (DEI) targets under pressure ...

The first designs have been released of the housing-led redevelopment of GlaxoSmithKline’s former west London HQ, drawn up by ...

Ten small & medium-sized charities have been named as winners of the 2025 GSK IMPACT Awards for their work improving health ...

The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

UK drugmaker GSK was one of the companies spending money away from the UK this month, agreeing to acquire US-based biotech IDRx for $1.15bn to bolster its oncology portfolio. The deal follows GSK’s ...

Secondary endpoint analyses from the trials showed 'significant improvements' in patients treated with the antibody.

Action on Postpartum Psychosis, a national charity that works across the UK to support mothers and their families, has ...

An ambitious London-based charity that has grown its impact across England has scooped one of this year’s GSK IMPACT Awards, ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...